This is a preview of subscription content, log in via an institution to check access.
Notes
A one-year head-to-head, randomised, controlled trial comparing glycopyrronium with tioptropium.
References
Costa-Scharplatz M, et al. Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in Copd Patients from a Swedish Societal Perspective. 16th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PRS33, 2 Nov 2013.
Torres C, et al. Cost-Effectiveness Analysis of Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease in Spain. 16th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PRS36, 2 Nov 2013.
Rights and permissions
About this article
Cite this article
Glycopyrronium dominates tiotropium in Sweden and Spain. PharmacoEcon Outcomes News 692, 9 (2013). https://doi.org/10.1007/s40274-013-0896-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0896-2